BIOMARIN PHARMACEUTICAL INC — Director's Dealing 2017

Mar 17, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOMARIN PHARMACEUTICAL INC (BMRN)
CIK: 0001048477
Period of Report: 2017-03-15

Reporting Person: BIENAIME JEAN JACQUES (Director, Chief Executive Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-03-15	Common Stock	M	5000	$17.33	Acquired	211364	Direct
2017-03-15	Common Stock	S	5000	$91.42	Disposed	206364	Direct
2017-03-15	Common Stock	F	15690	$92.50	Disposed	190674	Direct
2017-03-16	Common Stock	M	5000	$71.33	Acquired	195674	Direct
2017-03-16	Common Stock	S	5000	$91.96	Disposed	190674	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2017-03-15	Stock Option (Right to buy Common Stock)	$17.33	M	5000	Disposed	2017-06-06	Common Stock (5000)	Direct
2017-03-16	Stock Option (Right to buy Common Stock)	$17.33	M	5000	Disposed	2017-06-06	Common Stock (5000)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	182801	Indirect

Footnotes

F1: Trade made pursuant to a 10b5-1 plan executed on November 15, 2016.

F2: All shares were sold at the same price.

F3: Reflects the number of stock options outstanding after the transaction from this specific stock option grant.